How to Read Your Alpha-1 Lab Results
Published: | Updated:
To fully understand your Alpha-1 antitrypsin deficiency risk, doctors look at three test results: your total protein amount (serum level), your DNA blueprint (genotype), and the physical protein produced (phenotype). These combine to form your Pi type, which dictates your lung and liver risks.
Key Takeaways
- • A complete Alpha-1 diagnosis requires testing your serum level, genotype, and phenotype.
- • Serum levels measure the total Alpha-1 protein in your blood, but can appear artificially normal if you have an active infection or inflammation.
- • Genotype testing looks directly at your DNA to identify specific genetic variations, such as the normal M allele or the deficient Z allele.
- • Your Pi type (such as PiMM, PiMZ, or PiZZ) represents the combination of alleles you inherited and determines your overall risk for lung and liver disease.
When you receive your Alpha-1 lab results, the combination of medical terms can be overwhelming. To understand your complete diagnosis, you need to look at three different measurements that work together: your serum level (how much protein is in your blood), your genotype (your genetic blueprint), and your phenotype (the physical protein your body is making). By combining these three pieces of information, your doctor can determine if you have Alpha-1 antitrypsin deficiency (AATD), how severe it might be, and what risks you face [1][2][3].
1. Serum Level: The Amount of Protein
Your serum Alpha-1 antitrypsin level simply measures the total quantity of the Alpha-1 protein currently circulating in your blood [4][5]. This is usually the first screening test doctors order [1]. Your lab report will provide a “normal” reference range (often around 100–220 mg/dL or 20–53 micromoles, depending on the lab’s measurement system) so you can see if your number falls below the protective threshold [4].
However, there is a catch. Alpha-1 antitrypsin is known as an acute-phase reactant, meaning your body naturally produces more of it when you are sick, injured, or experiencing inflammation [4][6]. Because of this, if you happen to be fighting off an infection when your blood is drawn, your serum level might look completely normal even if you actually have a genetic deficiency [5][6]. Therefore, a serum level alone is not enough to make a definitive diagnosis [1].
2. Genotype: Your Genetic Blueprint
Your genotype is your specific DNA makeup, which you inherited from your parents. A genotype test looks directly at the SERPINA1 gene to see exactly which genetic variations (called alleles) you have [7][8]. Because it looks at your DNA, this test is highly accurate and is not affected by whether you are sick or healthy [7].
Everyone inherits two of these alleles—one from each parent. The most common alleles are assigned letters:
- M allele: This is the “normal” variation. It tells the body to produce normal amounts of healthy Alpha-1 protein [9][10].
- S allele: This is a mildly deficient variation [9].
- Z allele: This is a severely deficient variation that causes the protein to misfold and get trapped inside your liver, leading to very low levels of the protein in your blood [11][10][2].
There are also rare alleles, such as Null alleles, which produce no Alpha-1 protein at all [7][8]. If your report lists a letter other than M, S, or Z (such as F, I, or Null), your doctor can help explain how that specific rare variant affects you [3].
3. Phenotype: The Physical Protein
While your genotype looks at your DNA blueprint, your phenotype looks at the physical protein that your body is actually producing [2][12]. Lab technicians test this by seeing how the proteins move through a gel (a process called isoelectric focusing) [2][13]. While direct DNA testing (genotyping) is becoming the standard, phenotype testing remains an important tool to confirm that the proteins in your blood match what your genes suggest, especially if your serum level and genotype do not seem to align [3][13][7].
Putting It All Together: Your Lab Results
Your lab report will usually list your results as “Pi” followed by two letters representing the alleles you inherited. “Pi” stands for Protease Inhibitor, which simply refers to a protein that protects your body’s tissues (like your lungs) from damage [1][2]. Here is what the most common combinations mean:
- PiMM (Normal): You inherited two normal M genes. Your serum levels should be normal, and you do not have Alpha-1 antitrypsin deficiency [1][10].
- PiMS (Carrier / Mild): You inherited one normal M gene and one mildly deficient S gene. While your protein levels might be slightly lower than a PiMM individual, they are generally high enough to protect your lungs and liver, meaning this combination typically does not increase your disease risk [1][14].
- PiMZ (Carrier / Intermediate): You inherited one normal M gene and one severely deficient Z gene. Your serum levels will likely be lower than normal [1]. While you are a carrier, having PiMZ does increase your risk of developing lung disease (like COPD), especially if you smoke or are exposed to environmental pollutants [15][16].
- PiSZ (Intermediate/Severe): You inherited one S gene and one Z gene. This typically results in lower serum levels and a higher risk of disease than PiMZ, but is generally less severe than PiZZ [1][17].
- PiZZ (Severe Deficiency): You inherited two Z genes. This results in very low serum levels of Alpha-1 protein in the blood and significantly increases your risk of developing early-onset emphysema and liver disease [11][18][19]. If you have this result, doctors will likely discuss lifestyle precautions to protect your lungs and liver, such as avoiding alcohol and never smoking [10][15].
Understanding these three components—how much protein you have (serum level), what your DNA says (genotype), and what protein is physically present (phenotype)—allows your healthcare team to accurately diagnose your condition and tailor a monitoring or treatment plan specifically for you [1][3].
Frequently Asked Questions
What does a PiZZ Alpha-1 lab result mean?
Why is my Alpha-1 serum level normal if I have the deficient gene?
What is the difference between an Alpha-1 genotype and phenotype?
Do my family members need to be tested if my lab results show a deficiency?
Questions for Your Doctor
- • Given my specific genotype, do my blood relatives (like my siblings or children) need to be tested for Alpha-1?
- • Do my serum levels indicate that I need to start augmentation therapy, or are we just monitoring my lung function for now?
- • Are there any rare or 'Null' alleles on my lab report that would make my risk profile different from the standard M, S, and Z variants?
- • What lifestyle changes should I make immediately to protect my lungs and liver based on my Pi type?
- • Should I see a pulmonologist or a hepatologist (liver specialist) to establish a baseline for my organ health given my specific results?
Questions for You
- • Have any of my blood relatives been diagnosed with early-onset lung disease, liver disease, or COPD?
- • Was I experiencing any signs of illness or inflammation (like a cold, injury, or infection) when my blood was drawn that might have artificially raised my serum levels?
- • Am I currently a smoker, or am I regularly exposed to secondhand smoke, fumes, or occupational dust that could worsen my risk given my genotype?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Genotyping diagnosis of alpha-1 antitrypsin deficiency in Saudi adults with liver cirrhosis.
Al-Jameil N, Hassan AA, Buhairan A, et al.
Medicine 2017; (96(6)):e6071 doi:10.1097/MD.0000000000006071.
PMID: 28178162 - 2
Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis.
Greulich T, Vogelmeier CF
Therapeutic advances in respiratory disease 2016; (10(1)):72-84 doi:10.1177/1753465815602162.
PMID: 26341117 - 3
Alpha1 antitrypsin deficiency due to an homozygous PI* Null Q0Cairo mutation: Early onset of pulmonary manifestations and variability of clinical expression.
Jouhadi Z, Odou MF, Zerimech F, et al.
Respiratory medicine case reports 2018; (24()):58-62 doi:10.1016/j.rmcr.2018.04.005.
PMID: 29977761 - 4
Current and Emerging Treatments for Alpha-1 Antitrypsin Deficiency.
Perlmutter DH
Gastroenterology & hepatology 2016; (12(7)):446-8.
PMID: 27489528 - 5
Alpha-1 antitrypsin deficiency in a French General Hospital: fortuitous detection rather than efficient screening.
Moquet O, Kherouf H, de Faverges G, et al.
Advances in respiratory medicine 2018; (86(4)) doi:10.5603/ARM.a2018.0027.
PMID: 30173411 - 6
Maternal alpha-1-antitrypsin as a noval marker for growth restriction in pre-eclampsia.
Nori W, Ali AI
The journal of obstetrics and gynaecology research 2021; (47(12)):4250-4255 doi:10.1111/jog.15043.
PMID: 34571571 - 7
State-of-the-art testing for alpha-1 antitrypsin deficiency.
Kueppers F, Sanders C
Allergy and asthma proceedings 2017; (38(2)):108-114 doi:10.2500/aap.2017.38.4031.
PMID: 28120746 - 8
Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency.
Kueppers F, Andrake MD, Xu Q, et al.
BMC medical genetics 2019; (20(1)):125 doi:10.1186/s12881-019-0852-5.
PMID: 31307431 - 9
Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency.
Henao MP, Craig TJ
Expert review of respiratory medicine 2016; (10(12)):1281-1294 doi:10.1080/17476348.2016.1249851.
PMID: 27771979 - 10
Systematic review: the natural history of alpha-1 antitrypsin deficiency, and associated liver disease.
Townsend SA, Edgar RG, Ellis PR, et al.
Alimentary pharmacology & therapeutics 2018; (47(7)):877-885 doi:10.1111/apt.14537.
PMID: 29446109 - 11
[Alpha-1 antitrypsin deficiency].
Dasí F
Medicina clinica 2023; (160(5)):203-205 doi:10.1016/j.medcli.2022.09.001.
PMID: 36253208 - 12
Genetic diagnosis of α1-antitrypsin deficiency using DNA from buccal swab and serum samples.
Belmonte I, Barrecheguren M, Esquinas C, et al.
Clinical chemistry and laboratory medicine 2017; (55(9)):1276-1283.
PMID: 28107169 - 13
Measuring of Alpha-1 Antitrypsin Concentration by Nephelometry or Turbidimetry.
Marin-Hinojosa C, Fatela-Cantillo D, Lopez-Campos JL
Methods in molecular biology (Clifton, N.J.) 2024; (2750()):123-133 doi:10.1007/978-1-0716-3605-3_12.
PMID: 38108973 - 14
Therapeutics: Gene Therapy for Alpha-1 Antitrypsin Deficiency.
Gruntman AM, Flotte TR
Methods in molecular biology (Clifton, N.J.) 2017; (1639()):267-275 doi:10.1007/978-1-4939-7163-3_27.
PMID: 28752467 - 15
Alpha-1 Antitrypsin Replacement in Patients With COPD.
Wells AD, Woods A, Hilleman DE, Malesker MA
P & T : a peer-reviewed journal for formulary management 2019; (44(7)):412-415.
PMID: 31258312 - 16
Cancer risk in severe alpha-1-antitrypsin deficiency.
Hiller AM, Ekström M, Piitulainen E, et al.
The European respiratory journal 2022; (60(4)) doi:10.1183/13993003.03200-2021.
PMID: 35361631 - 17
Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease.
Balcar L, Scheiner B, Urheu M, et al.
JHEP reports : innovation in hepatology 2022; (4(11)):100562 doi:10.1016/j.jhepr.2022.100562.
PMID: 36176936 - 18
Alpha-1 antitrypsin deficiency and primary liver cancers.
Schneider CV, Decraecker M, Beaufrère A, et al.
Biochimica et biophysica acta. Reviews on cancer 2025; (1880(2)):189290 doi:10.1016/j.bbcan.2025.189290.
PMID: 39999944 - 19
Pulmonary Function and Respiratory Diseases in Different Genotypes of Alpha-1 Antitrypsin Deficiency.
Hernández Pérez JM, Suárez Sánchez JJ, López Charry CV, et al.
Turkish thoracic journal 2022; (23(6)):376-382 doi:10.5152/TurkThoracJ.2022.22001.
PMID: 35957569
This page explains Alpha-1 antitrypsin deficiency lab terminology for educational purposes only. Always review your specific genetic testing and serum levels with your pulmonologist, hepatologist, or genetic counselor.
Stay up to date
Get notified when new research about Alpha-1-antitrypsin deficiency is published.
No spam. Unsubscribe anytime.